These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11349746)

  • 21. Automated outreach to increase primary adherence to cholesterol-lowering medications.
    Derose SF; Green K; Marrett E; Tunceli K; Cheetham TC; Chiu VY; Harrison TN; Reynolds K; Vansomphone SS; Scott RD
    JAMA Intern Med; 2013 Jan; 173(1):38-43. PubMed ID: 23403978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Underutilization of lipid-lowering therapy in coronary artery disease.
    Batalla A; Hevia S; Reguero JR; Cubero GI
    Arch Intern Med; 2000 Sep; 160(17):2683-4. PubMed ID: 10999994
    [No Abstract]   [Full Text] [Related]  

  • 23. How can adherence to lipid-lowering medication be improved? A systematic review of randomized controlled trials.
    Schedlbauer A; Schroeder K; Fahey T
    Fam Pract; 2007 Sep; 24(4):380-7. PubMed ID: 17630270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trial experience with extended-release niacin (Niaspan): dose-escalation study.
    Goldberg AC
    Am J Cardiol; 1998 Dec; 82(12A):35U-38U; discussion 39U-41U. PubMed ID: 9915661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ezetimibe: caution in the face of doubt].
    Araujo F; Mateo de Castro J; Encinas Barrios C
    Farm Hosp; 2010; 34(4):212-4. PubMed ID: 20153227
    [No Abstract]   [Full Text] [Related]  

  • 26. Current perspectives on statins.
    Maron DJ; Fazio S; Linton MF
    Circulation; 2000 Jan; 101(2):207-13. PubMed ID: 10637210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Outcomes in Trials Evaluating Lipid-Lowering Drugs.
    Butters J; Brown A; Griffith L; Kim S; Nicholls SJ
    Am J Cardiovasc Drugs; 2017 Dec; 17(6):447-452. PubMed ID: 28432573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-adherence to lipid-lowering therapies: a need for more studies to evaluate reasons for medication non-adherence.
    Wong MC; Wang HH; Liu KS
    Int J Clin Pract; 2011 Dec; 65(12):1321-2. PubMed ID: 22093540
    [No Abstract]   [Full Text] [Related]  

  • 29. Drugs for treatment of patients with high cholesterol blood levels and other dyslipidemias.
    Bays HE; Dujovne CA
    Prog Drug Res; 1994; 43():9-41. PubMed ID: 7855253
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of adherence to prescribed medication.
    Insull W
    Adv Exp Med Biol; 1985; 183():349-60. PubMed ID: 3898749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Niacin: old habits die hard.
    Haynes R; Rahimi K
    Heart; 2016 Feb; 102(3):170-1. PubMed ID: 26769376
    [No Abstract]   [Full Text] [Related]  

  • 32. Niacin extended-release therapy in phase III clinical trials is associated with relatively low rates of drug discontinuation due to flushing and treatment-related adverse events: a pooled analysis.
    Brinton EA; Kashyap ML; Vo AN; Thakkar RB; Jiang P; Padley RJ
    Am J Cardiovasc Drugs; 2011 Jun; 11(3):179-87. PubMed ID: 21619381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin therapy: when to think twice.
    Wahawisan J; Tovar JM; Granberry MC
    J Fam Pract; 2013 Dec; 62(12):726-32. PubMed ID: 24340334
    [No Abstract]   [Full Text] [Related]  

  • 34. [Adherence to statin therapy and LDL cholesterol goal attainment in type 2 diabetics and secondary prevention patients: the role of education and knowledge].
    Yiğiner O; Ozmen N; Ozçelik F; Inanç T; Kardeşoğlu E; Uz O; Işılak Z; Aparcı M; Sahin I; Arslan E; Cebeci BS
    Turk Kardiyol Dern Ars; 2010 Dec; 38(8):544-50. PubMed ID: 21248454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals.
    Schectman G; Hiatt J
    Am J Med; 1996 Feb; 100(2):197-204. PubMed ID: 8629655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yamashita S
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of "group detailing" on the prescribing of lipid-lowering drugs: a randomized controlled trial in Swedish primary care.
    Diwan VK; Wahlström R; Tomson G; Beermann B; Sterky G; Eriksson B
    J Clin Epidemiol; 1995 May; 48(5):705-11. PubMed ID: 7730925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colesevelam.
    Melian EB; Plosker GL
    Am J Cardiovasc Drugs; 2001; 1(2):141-6; discussion 147-8. PubMed ID: 14728043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of statins on triglyceride metabolism.
    Ginsberg HN
    Am J Cardiol; 1998 Feb; 81(4A):32B-35B. PubMed ID: 9526811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of megatrials with antihyperlipidemic agents in Japan].
    Fukai S; Ouchi Y
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():270-4. PubMed ID: 17821901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.